Figure 8 illustrates the fate of dietary polyphenols within the human digestive system, beginning with their natural occurrence in fruits and vegetables as aglycones, glycosides, or bound forms

For currently approved GLP-1 receptor agonists available for weight management in the UK, NICE has established specific eligibility criteria: Semaglutide (Wegovy) NICE TA875 recommends semaglutide for adults with: A body mass index (BMI) of 35 kg/m or above with at least one weight-related comorbidity (such as hypertension, dyslipidaemia, obstructive sleep apnoea, or cardiovascular disease), or A BMI of 3034.9 kg/m with at least one weight-related comorbidity, prescribed only in specialist weight management services Evidence of previous unsuccessful weight loss attempts through diet, physical activity, and behavioural interventions Treatment is limited to a maximum of 2 years Liraglutide (Saxenda) NICE TA664 recommends liraglutide for adults with: A BMI of 35 kg/m or above (with or without comorbidities), or A BMI of 3034.9 kg/m with at least one weight-related comorbidity Evidence of previous unsuccessful weight loss attempts Treatment is limited to a maximum of 2 years Both medications must be prescribed as part of a specialist weight management service providing multidisciplinary support, including dietary advice, physical activity programmes, and behavioural interventions

Bacteriostatic water contains 0.9% benzyl alcohol, which prevents microbial contamination and allows multi-use access for up to 28 days making it more practical and cost-effective for researchers reconstituting multiple compounds
See this comparison article to learn more about the differences and similarities of Victoza and Saxenda
Its especially effective for those dealing with dullness, dark spots, or uneven skin tone